Aspen Aerogels (NYSE:ASPN - Get Free Report) was upgraded by Wall Street Zen from a "sell" rating to a "hold" rating in a note issued to investors on Saturday, Wall Street Zen reports.
A number of other brokerages have also weighed in on ASPN. B. Riley Financial restated a "buy" rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Barclays upped their price target on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an "underweight" rating in a research report on Tuesday, August 11th. Weiss Ratings reissued a "sell (d-)" rating on shares of Aspen Aerogels in a report on Monday, September 21st. Finally, Roth Capital reissued a "buy" rating and set a $7.75 price objective on shares of Aspen Aerogels in a report on Friday, August 7th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Aspen Aerogels currently has an average rating of "Hold" and a consensus target price of $5.94.
Get Our Latest Stock Report on Aspen Aerogels
Aspen Aerogels Price Performance
NYSE ASPN opened at $5.06 on Friday. Aspen Aerogels has a one year low of $2.30 and a one year high of $8.56. The stock's 50 day simple moving average is $5.25 and its 200 day simple moving average is $4.67. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.24 and a current ratio of 2.52.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. The firm had revenue of $49.85 million during the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. Sell-side analysts anticipate that Aspen Aerogels will post -0.69 EPS for the current fiscal year.
Insider Buying and Selling
In other Aspen Aerogels news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of the stock in a transaction on Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total value of $58,086,414.98. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.96% of the company's stock.
Institutional Investors Weigh In On Aspen Aerogels
Institutional investors and hedge funds have recently made changes to their positions in the company. WINTON GROUP Ltd acquired a new position in Aspen Aerogels during the 2nd quarter valued at about $388,000. Baird Financial Group Inc. acquired a new stake in shares of Aspen Aerogels during the 2nd quarter worth approximately $2,189,000. Concurrent Investment Advisors LLC grew its position in shares of Aspen Aerogels by 6.7% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 32,050 shares of the construction company's stock worth $203,000 after buying an additional 2,000 shares during the period. Headlands Technologies LLC acquired a new stake in shares of Aspen Aerogels during the 2nd quarter worth approximately $174,000. Finally, Equitable Holdings Inc. acquired a new stake in shares of Aspen Aerogels during the 2nd quarter worth approximately $88,000. Institutional investors own 97.64% of the company's stock.
About Aspen Aerogels
(
Get Free Report)
Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.
Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.